Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 912

1.

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.

Cannabis-In-Cachexia-Study-Group., Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, Meissner W, Ko YD, Schnelle M, Reif M, Cerny T.

J Clin Oncol. 2006 Jul 20;24(21):3394-400.

PMID:
16849753
2.

Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.

Yeh SS, Lovitt S, Schuster MW.

J Nutr Health Aging. 2009 May;13(5):448-54.

PMID:
19390752
3.

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT.

J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008.

PMID:
19896326
4.

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.

De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, Caraceni A.

Eur J Cancer. 1998 Oct;34(11):1705-9.

PMID:
9893656
5.

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.

Vadell C, Seguí MA, Giménez-Arnau JM, Morales S, Cirera L, Bestit I, Batiste E, Blanco R, Jolis L, Boleda M, Antón I.

Am J Clin Oncol. 1998 Aug;21(4):347-51.

PMID:
9708631
6.

Cancer cachexia and cannabinoids.

Gorter RW.

Forsch Komplementarmed. 1999 Oct;6 Suppl 3:21-2. Review.

PMID:
10575285
7.
8.

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.

Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL.

Cancer. 2007 Sep 15;110(6):1396-403.

11.
12.

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.

Tomíska M, Tomisková M, Salajka F, Adam Z, Vorlícek J.

Neoplasma. 2003;50(3):227-33.

PMID:
12937858
13.
14.
15.
16.

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.

Loprinzi CL, Ellison NM, Schaid DJ, Krook JE, Athmann LM, Dose AM, Mailliard JA, Johnson PS, Ebbert LP, Geeraerts LH.

J Natl Cancer Inst. 1990 Jul 4;82(13):1127-32.

PMID:
2193166
17.

Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis.

Leśniak W, Bała M, Jaeschke R, Krzakowski M.

Pol Arch Med Wewn. 2008 Nov;118(11):636-44. Review.

18.

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122).

Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L; RTOG..

Support Care Cancer. 2008 Oct;16(10):1179-88. doi: 10.1007/s00520-008-0403-7.

PMID:
18293016
19.

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.

Weber M, Goldman B, Truniger S.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1135-40. doi: 10.1136/jnnp.2009.200642.

PMID:
20498181
20.

Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.

Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J, Summers N, Brown B, Dulude H, Gallant G.

Cancer Prev Control. 1998 Apr;2(2):74-8.

PMID:
9765767
Items per page

Supplemental Content

Support Center